Muhammed Majeed,Kalyanam Nagabhushanam,Sivakumar Arumugam,Furqan Ali,Shaheen Majeed
申请号：
US16001096
公开号：
US20180344754A1
申请日:
2018.06.06
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed are compositions containing at least 10% w/w or above of 1-O-galloyl-β-D-glucose (β-glucogallin) which additionally comprising of about 10% w/w to greater than 60% w/w total mucic acid gallates including mucic acid 1,4-lactone 5-O-gallate, mucic acid 2-O-gallate, mucic acid 6-Methyl ester 2-O-gallate, mucic acid 1-Methyl ester 2-O-gallate and ellagic acid, and a probiotic bacteria Bacillus coagulans MTCC 5856, individually or in combination for inhibiting the growth and managing infections of Helicobacter pylori.
